10X Genomics Inc logo

TXG - 10X Genomics Inc Share Price

$65.95 2.8  4.4%

Last Trade - 9:00pm

Sector
Healthcare
Size
Large Cap
Market Cap £4.62bn
Enterprise Value £4.32bn
Revenue £168.3m
Position in Universe 1029th / 6405
Bullish
Bearish
Unlock TXG Revenue
Momentum
Relative Strength (%)
1m
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High
50d MA
200d MA
Margin of Safety
Qualifying GuruScreens
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

TXG Revenue Unlock TXG Revenue

Net Income

TXG Net Income Unlock TXG Revenue

Normalised EPS

TXG Normalised EPS Unlock TXG Revenue

PE Ratio Range

TXG PE Ratio Range Unlock TXG Revenue

Dividend Yield Range

TXG Dividend Yield Range Unlock TXG Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2019
31st Dec 2020
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
TXG EPS Forecasts Unlock TXG Revenue
Profile Summary

10x Genomics, Inc. life science technology company. The Company’s integrated solutions include instruments, consumables and software for analyzing biological systems at a resolution and scale that matches the complexity of biology. The Company’s product consists of chromium single cell gene expression solution, cell immune profiling solution, cell CNV solution, Cell assay for transposase accessible chromatin (ATAC) solution. The Company’s Chromium platform enables analysis of individual biological components, such as up to millions of single cells. Its Visium platform is designed to identify where biological components are located and how they are arranged with respect to each other. Its molecular assays are used with its Chromium platform, and with its planned Visium platform, to provide sensitive and robust biochemistries that convert minute amounts of biological analytes into detectable signals.

Directors
Last Annual December 31st, 2018
Last Interim September 30th, 2019
No. of Shareholders: n/a
No. of Employees: 557
Sector Healthcare
Industry Healthcare Equipment & Supplies
Index Nasdaq Composite ,
Exchange NASDAQ Global Select Market
Shares in Issue 96,169,954
Free Float (0.0%)
Eligible for
ISAs
SIPPs
TXG Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for TXG
Upcoming Events for TXG
Similar to TXG
© Stockopedia 2019, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.